Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Chinese Patent Office
Covington
Mallinckrodt
Healthtrust
Express Scripts
Merck
McKinsey
Boehringer Ingelheim

Generated: December 19, 2018

DrugPatentWatch Database Preview

ELSPAR Drug Profile

« Back to Dashboard

Summary for Tradename: ELSPAR

US Patents for ELSPAR

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Try a Free Trial EnBio Limited (Dublin, IE) ➤ Try a Free Trial RX search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Try a Free Trial Biogen Idec MA Inc. (Cambridge, MA) ➤ Try a Free Trial RX search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Try a Free Trial The American National Red Cross (Rockville, MD) ➤ Try a Free Trial RX search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Try a Free Trial Kuraray Co., Ltd. (Kurashiki, JP) ➤ Try a Free Trial RX search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Try a Free Trial 3-V Biosciences, Inc. (Menlo Park, CA) ➤ Try a Free Trial RX search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Try a Free Trial Dynavax Technologies Corporation (Berkeley, CA) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for ELSPAR

Supplementary Protection Certificates for ELSPAR

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2007000024 Germany ➤ Try a Free Trial PRODUCT NAME: PERFLUTREN ENTHALTENDE LIPID-MIKROPARTIKEL; REGISTRATION NO/DATE: EU/1/06/361/001 20060920
60031 Netherlands ➤ Try a Free Trial PRODUCT NAME: DOXORUBICINESULFAAT VERKREGEN UIT DOXORUBICINEHYDROCHLORIDE EN AMMONIUMSULFAAT; REGISTRATION NO/DATE: EU/1/96/011/001 - EU/1/96/011/002 19960621
325 Luxembourg ➤ Try a Free Trial PRODUCT NMAE. LUMINITY; REGISTRATION DATE: 20060920
27/2007 Austria ➤ Try a Free Trial PRODUCT NAME: PERFLUTREN ENTHALTENDE LIPID-MIKROPARTIKEL
C/GB96/053 United Kingdom ➤ Try a Free Trial PRODUCT NAME: DOXORUBICIN SULPHATE; REGISTERED: UK EU/1/96/011/001 19960621; UK EU/1/96/011/002 19960621
C0047 Belgium ➤ Try a Free Trial PRODUCT NAME: DOXORUBICIN HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/96/011/001 19960624
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Johnson and Johnson
Argus Health
Merck
Accenture
US Army
Farmers Insurance
Moodys
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.